在患有扩散性大B细胞淋巴瘤的患者中与标准治疗结合使用甲福明:一项随机的II期临床试验
Amira Hegazy1, Manar Salaheldin Ali1, Nabil Ahmed Mubarak1
1Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Shebin Al-Kom, Egypt.
Asian Pacific journal of cancer prevention : APJCP
|July 28, 2024
概括
在R-CHOP化疗中添加甲福明显著改善了扩散性大B细胞淋巴瘤 (DLBCL) 患者的结局,增加了完全缓解率和存活率,同时减少了复发. 这种组合显示出可以容忍的安全性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲胺在各种癌症中表现出抗瘤特性.
- 之前的研究表明,在分散型大B细胞淋巴瘤 (DLBCL) 患者中,在与前线化疗和免疫治疗一起接受甲福明治疗时,结果有所改善.
研究的目的:
- 评估将甲福明纳入用于初始DLBCL治疗的标准R-CHOP疗程的疗效和安全性.
- 关键指标包括应答率,毒性,无进展生存率 (PFS) 和整体生存率 (OS).
主要方法:
- 一个前性的2期临床试验,涉及100名成人DLBCL患者接受一线R-CHOP治疗.
- 患者被随机分为两组:一组接受甲福明加R-CHOP,另一组仅接受R-CHOP.
主要成果:
- 甲胺组显示显著更高的完全缓解 (92%对74%) 和改善的PFS (25.91对19.81个月) 和OS (27.39对23.8个月).
- 复发/进展率在甲胺组较低 (10%对36%),整体死亡率也较低 (4%对20%).
- 恶心在甲福林组中是一个更频繁的副作用,但整体毒性是可以容忍的.
结论:
- 将甲福明纳入标准R-CHOP疗法可以改善DLBCL患者的临床结果.
- 补充甲胺与改善生存率和降低复发率有关,具有可接受的安全性.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


